RE: Start of a re rating?29 Oct 2020 00:04
bcl, I think you’ve hit the nail on the head. Unfortunately, for me now, both KAT and MED are meaningless to KIBO.
KAT are still a long way from production, even if they are able to finalise project funding next month. They don’t even have a DFS for their Blyvoor project, so a raise at some point in the future is inevitable. The outcome is that KIBO’s share will be reduced further.
MED, to me is KAT all over again. Once it lists we’ll only have 51%. Don’t get me wrong, I think the lease payments are a good idea as a means of paying the EPC requirements. The drawback is that until it’s paid off (80 months later), there will be very little profit, if any at all. The result, once again, is that MED would have to return to the market to raise funds for ‘general working capital’. It’s a shame because once MED was first mentioned I thought it was a going to be great to have a number of near term projects bringing in revenue. All I can see now is that KIBO’s stake will gradually reduce over the next few years.
LC needs to focus more of his time getting Benga over the line. They’re looking at increasing its potential capacity to 400 MW. This puts it inline with one of my other holdings OPG, who have shown how profitable having just one 400 MW facility can be. Benga and ultimately KIBO definitely has potential, it just needs to get up and running.